BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4589396)

  • 1. A study of human cardiac allograft in a patient with four-year survival.
    Gotlieb AI; Crosby D; Lemire GG; Huang S
    Can Med Assoc J; 1974 Jan; 110(2):154-8. PubMed ID: 4589396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual origin of intimal cells in cardiac-allograft arteriosclerosis.
    Kennedy LJ; Weissman IL
    N Engl J Med; 1971 Oct; 285(16):884-7. PubMed ID: 4939537
    [No Abstract]   [Full Text] [Related]  

  • 3. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
    Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
    J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelialitis in accelerated allograft arteriosclerosis in human cardiac transplant recipients.
    Paavonen T; Mennander A; Lautenschlager I; Häyry P
    Transplant Proc; 1992 Feb; 24(1):342-3. PubMed ID: 1539307
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute vascular rejection involving the major coronary arteries of a cardiac allograft.
    Yowell RL; Hammond EH; Bristow MR; Watson FS; Renlund DG; O'Connell JB
    J Heart Transplant; 1988; 7(3):191-7. PubMed ID: 3290402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia.
    Alonso DR; Starek PK; Minick CR
    Am J Pathol; 1977 May; 87(2):415-42. PubMed ID: 322508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic features in long-term cardiac allografts.
    Pucci AM; Forbes RD; Billingham ME
    J Heart Transplant; 1990; 9(4):339-45. PubMed ID: 2398426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of coronary artery pathologic findings in human cardiac allografts.
    Johnson DE; Gao SZ; Schroeder JS; DeCampli WM; Billingham ME
    J Heart Transplant; 1989; 8(5):349-59. PubMed ID: 2795279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis.
    Gravanis MB
    Mod Pathol; 1989 Sep; 2(5):495-505. PubMed ID: 2813347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
    Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts.
    Adams DH; Karnovsky MJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):437-9. PubMed ID: 2650168
    [No Abstract]   [Full Text] [Related]  

  • 13. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial lesions of the human heart of a young person transplanted into a young person].
    Dallocchio M; Fontan F; Baudet E; Bezian J; Bricaud H; Pautrizel R; Broustet P
    Arch Mal Coeur Vaiss; 1970 Jul; 63(7):935-50. PubMed ID: 4990796
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intermediate and late changes in human cardiac graft].
    Chomette G; Auriol M; Desruennes M; Cabrol C
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1793-8. PubMed ID: 2125189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated coronary artery transplantation in pigs: a new model to study transplantation arteriosclerosis and humoral rejection.
    Tixier DB; Czer LS; Fishbein MC; Blanche C; Admon D; Amador R; Albert GD; Trento A
    J Heart Lung Transplant; 1996 Sep; 15(9):919-27. PubMed ID: 8889988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac allograft arteriosclerosis and myocardial necrosis].
    Song G; Song H; Zhang Z
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):303-5, 20. PubMed ID: 12828180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic findings in long-term cardiac transplants.
    Uys CJ; Rose AG
    Arch Pathol Lab Med; 1984 Feb; 108(2):112-6. PubMed ID: 6365025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rejection in the atrioventricular node and bundles with the working myocardium in transplanted hearts.
    Chang AC; Hruban RH; Levin HR; Baughman KL; Baumgartner WA; Reitz BA; Hutchins GM
    J Heart Lung Transplant; 1991; 10(6):915-20. PubMed ID: 1756156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.